ArticleFrontiers in pharmacology2023

Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.

A Iurlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.